骨髄異形成症候群における臨床試験報告の標準化:International Consortium for MDSによる重要提言

Aligning Clinical Trial Reporting in Myelodysplastic Syndromes: Key Recommendations from the International Consortium for MDS

The International Consortium for MDS issues a consensus to standardize clinical trial reporting in MDS—defining required baseline elements, harmonized endpoints (including transfusion independence and overall response), safety reporting, and templates to improve interpretability and regulatory decision-making.